SCHEMBL14744225

SCHEMBL14744225

CS(=O)(=O)c1cnc(N)nc1NCCc1cc2cccc(Cl)c2c(=O)n1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 19/20 0.43
PIK3R1 P27986 8/20 0.43
PIK3CG P48736 15/20 0.41
PIK3R2 O00459 5/20 0.39
ABCB11 O95342 1/20 0.39
TBXA2R P21731 1/20 0.39
HTR2A P28223 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CB P42338 1/20 0.39
PDE3A Q14432 1/20 0.39
KCNJ5 P48544 1/20 0.37
KCNJ3 P48549 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14744075 0.86 PIK3CD (0.43) PIK3CDPIK3R1PIK3CGPIK3R2ABCB11
SCHEMBL14743894 0.85 PIK3CD (0.42) PIK3CDPIK3R1PIK3CGPIK3R2ABCB11
SCHEMBL935877 0.82 PIK3CD (0.41) PIK3CDPIK3R1PIK3CGPIK3R2PIK3CB
SCHEMBL15820628 0.81 PIK3CD (0.53) PIK3CDPIK3R1PIK3CGPIK3R2PIK3CA
SCHEMBL14718673 0.81 PIK3CD (0.57) PIK3CDPIK3R1PIK3CGPIK3R2ABCB11
SCHEMBL14718674 0.81 PIK3CD (0.57) PIK3CDPIK3R1PIK3CGPIK3R2ABCB11
SCHEMBL935671 0.75 PIK3CD (0.51) PIK3CDPIK3R1PIK3CGABCB11TBXA2R
SCHEMBL14729932 0.75 PIK3CD (0.58) PIK3CDPIK3R1PIK3CGPIK3R2PIK3CA
SCHEMBL17262981 0.74 PIK3CB (0.47) PIK3CDPIK3R1PIK3CGPIK3CAPIK3CB
SCHEMBL17235373 0.73 PIK3CD (0.73) PIK3CDPIK3R1PIK3CGPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2751093-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF Infinity Pharmaceuticals, Inc. (US) 2014-07-09 EP disclosed
WO-2013032591-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS INC. (US) 2013-03-07 WO disclosed